These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22596268)

  • 1. Biochemical studies of poly-T variants in the Alzheimer's disease associated TOMM40 gene.
    Hedskog L; Brohede J; Wiehager B; Pinho CM; Revathikumar P; Lilius L; Glaser E; Graff C; Karlström H; Ankarcrona M
    J Alzheimers Dis; 2012; 31(3):527-36. PubMed ID: 22596268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.
    Johnson SC; La Rue A; Hermann BP; Xu G; Koscik RL; Jonaitis EM; Bendlin BB; Hogan KJ; Roses AD; Saunders AM; Lutz MW; Asthana S; Green RC; Sager MA
    Alzheimers Dement; 2011 Jul; 7(4):456-65. PubMed ID: 21784354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity.
    Maruszak A; Pepłońska B; Safranow K; Chodakowska-Żebrowska M; Barcikowska M; Zekanowski C
    J Alzheimers Dis; 2012; 28(2):309-22. PubMed ID: 22008263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3.
    Li G; Bekris LM; Leong L; Steinbart EJ; Shofer JB; Crane PK; Larson EB; Peskind ER; Bird TD; Yu CE
    Alzheimers Dement; 2013 Sep; 9(5):554-61. PubMed ID: 23183136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of TOMM40 poly-T repeat lengths on age of onset and cerebrospinal fluid biomarkers in Finnish Alzheimer's disease patients.
    Helisalmi S; Hall A; Meriläinen EH; Väisänen V; Koivisto AM; Herukka SK; Laitinen M; Soininen H; Hiltunen M
    Neurodegener Dis; 2014; 14(4):204-8. PubMed ID: 25500937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.
    Cruchaga C; Nowotny P; Kauwe JS; Ridge PG; Mayo K; Bertelsen S; Hinrichs A; Fagan AM; Holtzman DM; Morris JC; Goate AM;
    Arch Neurol; 2011 Aug; 68(8):1013-9. PubMed ID: 21825236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.
    Chiba-Falek O; Gottschalk WK; Lutz MW
    Alzheimers Dement; 2018 May; 14(5):692-698. PubMed ID: 29524426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.
    Linnertz C; Anderson L; Gottschalk W; Crenshaw D; Lutz MW; Allen J; Saith S; Mihovilovic M; Burke JR; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
    Alzheimers Dement; 2014 Sep; 10(5):541-51. PubMed ID: 24439168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment.
    Laczó J; Andel R; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Lerch O; Gazova I; Moffat SD; Hort J
    Neurobiol Aging; 2015 Jun; 36(6):2024-33. PubMed ID: 25862420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
    Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease.
    Roses AD; Lutz MW; Amrine-Madsen H; Saunders AM; Crenshaw DG; Sundseth SS; Huentelman MJ; Welsh-Bohmer KA; Reiman EM
    Pharmacogenomics J; 2010 Oct; 10(5):375-84. PubMed ID: 20029386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
    Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
    PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.
    Siddarth P; Burggren AC; Merrill DA; Ercoli LM; Mahmood Z; Barrio JR; Small GW
    PLoS One; 2018; 13(12):e0208358. PubMed ID: 30517207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease.
    Chu SH; Roeder K; Ferrell RE; Devlin B; DeMichele-Sweet MA; Kamboh MI; Lopez OL; Sweet RA
    Neurobiol Aging; 2011 Dec; 32(12):2328.e1-9. PubMed ID: 21820212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
    Lindqvist D; Prokopenko I; Londos E; Middleton L; Hansson O
    J Parkinsons Dis; 2016; 6(1):99-108. PubMed ID: 26756745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.
    Mastaglia FL; Rojana-udomsart A; James I; Needham M; Day TJ; Kiers L; Corbett JA; Saunders AM; Lutz MW; Roses AD;
    Neuromuscul Disord; 2013 Dec; 23(12):969-74. PubMed ID: 24103330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the poly-T variant in the TOMM40 gene in diverse populations.
    Linnertz C; Saunders AM; Lutz MW; Crenshaw DM; Grossman I; Burns DK; Whitfield KE; Hauser MA; McCarthy JJ; Ulmer M; Allingham R; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
    PLoS One; 2012; 7(2):e30994. PubMed ID: 22359560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.
    Burggren AC; Mahmood Z; Harrison TM; Siddarth P; Miller KJ; Small GW; Merrill DA; Bookheimer SY
    Alzheimers Dement; 2017 Jul; 13(7):739-748. PubMed ID: 28183529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease.
    Zeitlow K; Charlambous L; Ng I; Gagrani S; Mihovilovic M; Luo S; Rock DL; Saunders A; Roses AD; Gottschalk WK
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2973-2986. PubMed ID: 28768149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE ε4-negative elderly.
    Pomara N; Bruno D; Sidtis JJ; Lutz MW; Greenblatt DJ; Saunders AM; Roses AD
    J Clin Psychopharmacol; 2011 Aug; 31(4):544-6. PubMed ID: 21720235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.